Henry J F, Sebag F, Maweja S, Hubbard J, Misso C, Da Costa V, Tardivet L
Service de chirurgie générale et endocrinienne, hôpital de la Timone, 264, rue Saint-Pierre, 13385 Marseille 05, France.
Ann Chir. 2003 Jul;128(6):379-84. doi: 10.1016/s0003-3944(03)00110-x.
In recent years, different minimally invasive techniques of parathyroidectomy have been described. We performed a retrospective study to evaluate the indications and results of video-assisted parathyroidectomy (Vap) in the management of our patients with primary hyperparathyroidism (PHPT).
During the last 5 years (1998-2002), we operated on 528 patients with PHPT. Vap was proposed for patients with sporadic PHPT, without associated goiter and without previous neck surgery, in whom a single adenoma was localized by means of sonography and/or sestamibi scanning. Vap was performed by lateral approach with insufflation for patients with adenoma located deeply in the neck and by gasless midline approach for patients with adenoma located anteriorly. A quick parathyroid (qPTH) assay was used during the surgical procedures. Calcemia, phosphoremia and PTH were systematically evaluated in patients on days 1 and 8, 1 month and 1 year after surgery. All patients underwent pre-operative and postoperative investigations of vocal cord movements.
Among 528 patients with PHPT, 228 (43%) were not eligible for Vap: associated nodular goiter (99 cases), previous neck surgery (42 cases), suspicion of multiglandular disease (25 cases), lack of pre-operative localization (48 cases), and miscellaneous causes (14 cases). Vap was performed in 300 patients with sporadic PHPT: 282 lateral access, 17 midline access and 1 thoracoscopy. Median operative time was 50 min (20-130 min). Conversion to conventional parathyroidectomy was required in 42 patients (14%): missed adenomas (11 cases), difficulties of dissection (7 cases), multiglandular disease correctly predicted by qPTH (10 cases); qPTH assay false negative results (3 cases), sestamibi scan false positive results (10 cases) and 1 sonography false positive result. One patient presented definitive recurrent nerve palsy. One patient had a persistent PHPT and one other patient had a recurrent PHPT.
Vap can be proposed for more than half of patients with PHPT. In our experience Vap and conventional parathyroidectomy are complementary. Immediate results of Vap are similar to those obtained with conventional parathyroidectomy but no conclusions can be drawn in terms of influence of Vap on the outcome of the patients operated for PHPT.
近年来,已描述了不同的甲状旁腺切除术微创技术。我们进行了一项回顾性研究,以评估电视辅助甲状旁腺切除术(Vap)在治疗原发性甲状旁腺功能亢进症(PHPT)患者中的适应症和结果。
在过去5年(1998 - 2002年)期间,我们对528例PHPT患者进行了手术。对于散发性PHPT、无相关甲状腺肿且无既往颈部手术史、通过超声和/或 sestamibi 扫描定位为单个腺瘤的患者,建议采用Vap。对于腺瘤位于颈部深处的患者,通过侧方入路并注入气体进行Vap;对于腺瘤位于前方的患者,通过无气中线入路进行Vap。手术过程中使用快速甲状旁腺素(qPTH)检测。在术后第1天和第8天、1个月和1年,系统评估患者的血钙、血磷和甲状旁腺素。所有患者均接受术前和术后声带运动检查。
在528例PHPT患者中,228例(43%)不符合Vap条件:合并结节性甲状腺肿(99例)、既往颈部手术史(42例)、怀疑多腺体疾病(25例)、术前未定位(48例)以及其他原因(14例)。对300例散发性PHPT患者进行了Vap:282例采用侧方入路,17例采用中线入路,1例采用胸腔镜手术。中位手术时间为50分钟(20 - 130分钟)。42例患者(14%)需要转为传统甲状旁腺切除术:腺瘤遗漏(11例)、解剖困难(7例)、qPTH正确预测多腺体疾病(10例);qPTH检测假阴性结果(3例)、sestamibi扫描假阳性结果(10例)和1例超声假阳性结果。1例患者出现永久性喉返神经麻痹。1例患者持续性PHPT,另1例患者复发性PHPT。
超过一半的PHPT患者可考虑采用Vap。根据我们的经验,Vap和传统甲状旁腺切除术是互补的。Vap的即时结果与传统甲状旁腺切除术相似,但就Vap对接受PHPT手术患者的预后影响而言,尚无定论。